Alexion Reports Fourth Quarter and Full Year 2015 Results and Provides Financial Guidance for 2016

Go back to Alexion Reports Fourth Quarter and Full Year 2015 Results and Provides Financial Guidance for 2016
Alexion Pharmaceuticals (NASDAQ: ALXN) Delayed: 182.01 --0 (-0%)
Previous Close $182.01    52 Week High $193.45 
Open $33.31    52 Week Low $110.56 
Day High $182.01    P/E 143.31 
Day Low $182.01    EPS $1.27 
Volume 71